Composition
- Active ingredients
- NAFCILLIN SODIUM EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NAFCILLIN SODIUM EQ 500MG BASE · TabletNDA050462-001 · Discontinued
- NAFCILLIN SODIUM EQ 250MG BASE/5ML · For solutionNDA050199-001 · Discontinued
- NAFCILLIN SODIUM EQ 250MG BASE · CapsuleNDA050111-001 · Discontinued
- NAFCILLIN SODIUM EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableANDA062717-004 · Discontinued
- NAFCILLIN SODIUM EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- NAFCILLIN SODIUM EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableANDA062717-001 · Discontinued
- NAFCILLIN SODIUM EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050320-005 · Discontinued
- NAFCILLIN SODIUM EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050320-003 · Discontinued
- NAFCILLIN SODIUM EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable
At a glance
- Brand name
- Unipen
- Active substance
- nafcillin sodium
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Wyeth Ayerst
- Status
- Discontinued
- Application
- ANDA062717-002